The effect of tyrosine kinase inhibition on phorbol 12,13-dibutyrate- and ionomycin-induced LH and GH release.
Johnson
M S
MS
MRC Brain Metabolism Unit, Edinburgh, UK.
Noble
J
J
Wolbers
W B
WB
Mitchell
R
R
D000818:Animals; D002934:Cinnamates / Q000494:pharmacology*; D013006:Growth Hormone / Q000378:metabolism*; D066298:In Vitro Techniques; D015759:Ionomycin / Q000494:pharmacology*; D007700:Kinetics; D007986:Luteinizing Hormone / Q000378:metabolism*; D015240:Phorbol 12,13-Dibutyrate / Q000494:pharmacology*; D010903:Pituitary Gland, Anterior / Q000187:drug effects / Q000201:enzymology / Q000378:metabolism*; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors*; D051381:Rats
D002934:Cinnamates; D015240:Phorbol 12,13-Dibutyrate; D015759:Ionomycin; C067472:methyl 2,5-dihydroxycinnamate; D007986:Luteinizing Hormone; D013006:Growth Hormone; D011505:Protein-Tyrosine Kinases